Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02677324
Recruitment Status : Active, not recruiting
First Posted : February 9, 2016
Last Update Posted : May 2, 2019
Sponsor:
Collaborator:
AbbVie
Information provided by (Responsible Party):
Jorge J. Castillo, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2022